Global Blood Therapeutics, Inc. Current Assets
Global Blood Therapeutics, Inc. had Current Assets of $640.01 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2022-08-08
- 2022-06-30: Assets, Current $640.01M.
- 2022-03-31: Assets, Current $675.65M.
- 2021-12-31: Assets, Current $801.97M.
- 2021-09-30: Assets, Current $488.86M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2022-06-30 | $640.01M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $675.65M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $801.97M 10-Q · filed 2022-08-08 | |
| 2021-09-30 | $488.86M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $524.86M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $558.13M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $632.16M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $594.66M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $594.03M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $564.47M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $628.00M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $615.80M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $666.76M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $465.49M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $485.78M 10-K · filed 2020-02-26 | |
| 2018-09-30 | $392.18M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $469.54M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $553.85M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $324.31M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $229.77M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $234.85M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $248.32M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $149.77M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $221.27M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $234.10M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $136.54M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $149.72M 10-K · filed 2017-03-13 | $150.82M 10-K · filed 2016-03-29 |
| 2015-09-30 | $160.73M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $42.41M 10-Q · filed 2015-09-24 | |
| 2014-12-31 | $53.59M 10-K · filed 2016-03-29 |